Peter Lehre
About Peter Lehre
Peter Lehre is the Associate Medical Director at BeiGene in Deutschland, with over 20 years of experience in the pharmaceutical and medical fields, particularly in oncology and hematology.
Current Position at BeiGene
Peter Lehre is currently employed as the Associate Medical Director at BeiGene in Deutschland. In this role, he leverages his extensive experience in medical affairs and oncology to contribute to the company's objectives in providing innovative cancer treatments. His current responsibilities include managing medical strategies and ensuring the alignment of clinical development with BeiGene's vision.
Previous Roles at Oncopeptides AB and Bristol Myers Squibb
Before joining BeiGene, Peter Lehre briefly held the position of Country Medical Director for Germany & Austria at Oncopeptides AB in 2021. Additionally, in the same year, he worked as the MSL Lead Hematology at Bristol Myers Squibb for five months. In these roles, he focused on medical science liaison activities and contributed to advancing hematology-related initiatives.
Extensive Experience at Celgene
Peter Lehre spent a significant part of his career at Celgene, where he held various roles for a total of eight years. From 2019 to 2021, he was the MSL Lead Hematology. Prior to that, he served as the Senior Manager Medical Affairs/Disease Area Lead for Lymphoma & CLL from 2014 to 2018. He also worked as the Regional Medical Liaison Hematology from 2010 to 2014. His work primarily focused on hematology and included managing disease areas and liaising with medical and scientific communities.
Career Beginnings at AstraZeneca and Janssen
Peter Lehre began his career in the pharmaceutical industry at AstraZeneca, where he worked as a Key-Account-Manager Onkologie from 1998 to 2004. He then moved to The Janssen Pharmaceutical Companies of Johnson & Johnson, where he held the roles of Fachreferent Hamatologie-Onkologie and Medical Science Liaison Hämatologie-Onkologie from 2004 to 2010. During his time at Janssen, he focused on hematology-oncology, establishing a strong foundation for his future roles in medical affairs.
Educational Background
Peter Lehre has a diverse educational background. He studied Marine Mikrobiologie at Christian-Albrechts-Universität zu Kiel, where he earned a Diplom. Additionally, he participated in an EU Large Scale Facilities Project at Universitetet i Bergen (UiB). His educational experiences provided a solid scientific foundation, which he has applied throughout his extensive career in the pharmaceutical and medical fields.